Purity: HPLC법(또는 약전 개별 규격)에 따른 건조물 기준 함량 98.0% 이상으로, 의약품/공업용 등급 규격에 부합합니다.
Loss on Drying: 건조감량 0.5% w/w 이하로, 약전 방법(USP <731> / Ph. Eur. 2.2.32)에 따라 측정됩니다.
Residual Solvents: 잔류 용매는 해당 용매 등급에 대한 ICH Q3C 한도 이내로 관리됩니다.
불순물 프로파일: 개별 미지정 불순물 0.10% 이하, 총 불순물 0.50% 이하로 ICH Q3A/B 가이드라인을 준수합니다.

기타 정보

추가 설명:

Building on strong chemical development and manufacturing capabilities, Laurus Labs has built an in-house range of APIs and related intermediates, targeting chemistries where it can add real value—pairing innovation with efficiency through cost-effective processes and matching capacity investment for supply reliability. Laurus ranks among the world's leading suppliers of anti-retroviral APIs and intermediates, with low-cost technologies intended to widen medicine access globally. The company partners closely with innovators, global health organizations, and providers to meet cost-reduction goals without compromising quality, and its facilities for handling highly potent materials at development and commercial scale support oncology as a core focus area.